You are here

Advancing Precision Blood™: New Funding and Clinical Trial Partnership with Rady Children’s Hospital

We are thrilled to announce a significant milestone for our Precision Blood™ initiative, an innovative approach aims that to revolutionize blood transfusions by matching donors and recipients across more than 30 different blood groups using 300 antigen markers. Thanks to generous funding from the Cushman Foundation and the David C. Copley Foundation, we are set to take Precision Blood to the next level.

Leveraging Funding to Drive Clinical Trials and Community Engagement

This significant financial backing serves as the cornerstone for our next steps. These funds will enable us to:

  • Purchase a tube sorter machine to increase our processing capabilities.
  • Expand our lab space to house the necessary equipment and scaled operations.
  • Move forward with clinical studies and research.

With the necessary resources in place, we are launching a pivotal clinical trial in collaboration with Rady Children’s Hospital - San Diego. This trial will explore the benefits of precise blood matching in improving medical outcomes for patients requiring chronic transfusions.

Community support is vital for the success of our Precision Blood initiative. That's why we're excited to announce a matching grant opportunity available until June 1, 2024. Your contributions could be doubled, further enabling the expansion of this groundbreaking program. We are also actively seeking to diversify our blood donor pool to ensure success.

How You Can Help

  • Donate Blood: Every drop counts in making this initiative a success.
  • Financial Contributions: Help us meet our matching grant challenge.
  • Spread the Word: Share this blog post and our mission with your network.

We are incredibly grateful for the community's support and are optimistic about the transformative impact this will have on healthcare. Together, we can make a difference in the lives of patients in need.

Read the full press release and announcement →

Wednesday, September 20, 2023